Gliclapack 60mg Tablet ER is a medication primarily used to manage type 2 diabetes mellitus in adult patients. This medication falls under the classification of sulfonylureas, a group of drugs known to aid in regulating blood sugar levels in individuals with diabetes. By effectively controlling blood sugar, Gliclapack 60mg Tablet ER plays a crucial role in mitigating severe complications associated with diabetes, such as kidney damage and vision problems.

Patients may receive a prescription for Gliclapack 60mg Tablet ER either as a standalone treatment or in conjunction with other diabetes medications. It is recommended to take this medicine with food consistently at the same time every day to maximize its benefits. The appropriate dosage will be determined by your healthcare provider and may be adjusted based on its effectiveness in managing blood sugar levels over time.

Continued use of Gliclapack 60mg Tablet ER is emphasized, even if you feel well or have successfully controlled your blood sugar levels. Discontinuing the medication without medical consultation can result in a spike in blood sugar levels, increasing the risk of complications like kidney damage, vision impairment, nerve issues, and potential limb loss. It is essential to understand that Gliclapack 60mg Tablet ER should be complemented with a comprehensive treatment regimen that includes a healthy diet, regular physical activity, and weight management guidance from your healthcare provider, highlighting the significant role lifestyle modifications play in diabetes management.

Common side effects associated with Gliclapack 60mg Tablet ER may include indigestion and stomach discomfort, as well as the potential for low blood glucose levels (hypoglycemia). Patients are advised to be aware of signs indicating low blood sugar, such as sweating, dizziness, headaches, and tremors, and should have fast-acting glucose sources like sugary snacks or fruit juice readily available to address any emergent hypoglycemic episodes. Consumption of alcohol while on this medication should be avoided, as it can heighten the risk of blood sugar drops. Some individuals may experience weight gain as a side effect of taking Gliclapack 60mg Tablet ER.

Specific contraindications for Gliclapack 60mg Tablet ER include not being suitable for individuals with type 1 diabetes mellitus, diabetic ketoacidosis (elevated blood acid levels), or severe kidney or liver conditions. Patients with a history of heart issues, thyroid disorders, or certain hormonal imbalances should inform their healthcare provider before starting this medication to assess its appropriateness. Pregnant or breastfeeding individuals should seek medical advice before initiating treatment with Gliclapack 60mg Tablet ER. Regular monitoring of blood sugar levels and potential blood tests to evaluate blood cell counts and liver function may be recommended by your doctor during the course of treatment.